Nightingale Health Oyj (HEL:HEALTH)
Finland · Delayed Price · Currency is EUR 0.8580
+0.0340 (4.13%)
At close: Jul 27, 2026
Nightingale Health Oyj Income Statement
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 4.8 | 4.69 | 4.36 | 4.18 | 2.31 | 2.31 | |
Revenue Growth | 2.20% | 7.69% | 4.21% | 80.80% | 0.35% | 29.43% |
Cost of Revenue | 1.57 | 1.16 | 1.46 | 0.59 | 1.04 | 0.32 |
Gross Profit | 3.23 | 3.54 | 2.9 | 3.59 | 1.28 | 1.99 |
Selling, General & Admin | 8.71 | 8.6 | 8.78 | 9.38 | 6.5 | 6.37 |
Depreciation & Amortization Expenses | 7.32 | 8.29 | 8.16 | 6.69 | 4.24 | 2.45 |
Other Operating Expenses | 6.29 | 6.07 | 4.55 | 6.05 | 4.17 | 2.92 |
Total Operating Expenses | 22.32 | 22.96 | 21.49 | 22.12 | 14.91 | 11.74 |
Operating Income | -19.09 | -19.42 | -18.59 | -18.53 | -13.63 | -9.75 |
Interest Income | 1.14 | 2.3 | 2.01 | 1.17 | 0.69 | 2.26 |
Interest Expense | -1.08 | -1.29 | -0.8 | -0.82 | -1.18 | -2.23 |
Other Non-Operating Income (Expense) | - | - | - | 0.09 | -2.07 | - |
Total Non-Operating Income (Expense) | 0.06 | 1.01 | 1.22 | 0.45 | -2.56 | 0.03 |
Pretax Income | -19.03 | -18.41 | -17.37 | -18.08 | -16.19 | -9.72 |
Provision for Income Taxes | -0.07 | -0.07 | -0.07 | -0.01 | 0.1 | -0 |
Net Income | -19.07 | -18.46 | -17.46 | -18.08 | -16.09 | -9.73 |
Net Income to Common | -19.07 | -18.46 | -17.46 | -18.08 | -16.09 | -9.73 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 61 | 60 | 60 | 60 | 60 | 42 |
Shares Outstanding (Diluted) | 61 | 60 | 60 | 60 | 60 | 42 |
Shares Change | 0.97% | 0.01% | - | 0.17% | 44.56% | 22.85% |
EPS (Basic) | -0.32 | -0.31 | -0.29 | -0.30 | -0.27 | -0.23 |
EPS (Diluted) | -0.32 | -0.31 | -0.29 | -0.30 | -0.27 | -0.23 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -15.26 | -14.26 | -13 | -11.74 | -8.85 | -2.77 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.25 | -0.24 | -0.22 | -0.19 | -0.15 | -0.07 |
Gross Margin | 67.37% | 75.39% | 66.45% | 85.89% | 55.17% | 86.16% |
Operating Margin | -398.02% | -413.74% | -426.57% | -442.97% | -589.45% | -423.17% |
Profit Margin | -397.69% | -393.37% | -400.71% | -432.40% | -695.68% | -421.91% |
FCF Margin | -318.24% | -303.90% | -298.21% | -280.80% | -382.49% | -120.04% |
EBITDA | -11.77 | -11.12 | -10.43 | -11.84 | -9.39 | -7.3 |
EBITDA Margin | -245.43% | -237.01% | -239.38% | -283.02% | -405.97% | -316.75% |
EBIT | -19.09 | -19.42 | -18.59 | -18.53 | -13.63 | -9.75 |
EBIT Margin | -398.02% | -413.74% | -426.57% | -442.97% | -589.45% | -423.17% |
Effective Tax Rate | 0.37% | 0.39% | 0.37% | 0.05% | -0.64% | 0.02% |